Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment Certara Inc CERT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Solid Operational Progress GLP Q1 2026 Earnings Massive EPS Surprise of 455 Overshadows Lack of Revenue Disclosure PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines QTTB Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory